Study Objective To understand the impact of implementation of hospital system wide narcotic prescribing guidelines on patient narcotic usage after gynecologic surgery. Design Descriptive Quality Improvement project. Setting Academic tertiary… Click to show full abstract
Study Objective To understand the impact of implementation of hospital system wide narcotic prescribing guidelines on patient narcotic usage after gynecologic surgery. Design Descriptive Quality Improvement project. Setting Academic tertiary care center. Patients or Participants All patients undergoing gynecologic surgery in December of 2017 and December of 2018. Interventions All patients undergoing gynecologic procedure in December of 2017 had their charts reviewed and a selection were called and interviewed up to 4 weeks post operation to assess their narcotic usage and pain control. Stringent prescribing guidelines were implemented in May 2018 as part of a quality improvement project. This procedure was repeated with all patients undergoing gynecologic surgery in December of 2018. Measurements and Main Results For minimally invasive hysterectomy (robotic, vaginal, laparoscopic) (n=30 in 2017, 28 in 2018) hospital administered oral morphine equivalents (OME) remained the same 73.6 in 2017 to 78.9 in 2018 (p0.63). There was a significant decrease in discharge OME from 177.8 in 2017 to 117.8 in 2018 (p Conclusion Stringent opiate prescribing guidelines led to decreased opiate prescription on discharge across all types of gynecologic surgery.
               
Click one of the above tabs to view related content.